Profil bibliographique

Fiona G. Brown

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

104Publications signalées
5195Citations signalées
2Affiliations récentes

Institutions déclarées

Monash HealthMonash University

Domaines associés

Dialysis and Renal Disease ManagementCentral Venous Catheters and HemodialysisAcute Kidney Injury ResearchChronic Kidney Disease and DiabetesKidney Stones and Urolithiasis Treatments

Publications récentes

Accès ouvert 2021 erratum

Corrigendum to “Rondeau E, Scully M, Ariceta G, Barbour T, Cataland S, Heyne N, Miyakawa Y, Ortiz S, Swenson E, Vallee M, Yoon S-S, Kavanagh D and Haller H; on behalf of the 311 Study Group. The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment.” Kidney Int. 2020;97:1287–1296

Éric Rondeau, Marie Scully, Gema Ariceta, Spero Cataland et autres

3 citationsKidney International
Accès ouvert 2020 erratum

Erratum to “Rondeau E, Scully M, Ariceta G, Barbour T, Cataland S, Heyne N, Miyakawa Y, Ortiz S, Swenson E, Vallee M, Yoon S-S, Kavanagh D, Haller H; on behalf of the 311 Study Group. The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment” Kidney Int. 2020;97:1287–1296

Éric Rondeau, Marie Scully, Gema Ariceta, Spero Cataland et autres

3 citationsKidney International
Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.